Health Condition 1: L659- Nonscarring hair loss, unspecified
Conditions
Interventions
Intervention1: XY1920: 1 capsule daily for oral consumption after breakfast with plenty of water for 3 months
Control Intervention1: AB1921: 1 pill daily for oral consumption after breakfast with plen
Sponsors
Monkey Creations Inc MCI
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female subjects in general good health. 2. Subjects in the age group 18-55 years (both the ages inclusive). 3. Subjects complaining of hair fall and damage. 4. Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol. 5. Hair density of >100 and per Trichoscan measurement 6. Female Subjects falling under Grade 3 - Grade 6 of hair loss severity, grade evaluated as per photo numerical10 point scale (Linear scale for assessment purpose-MSCR Scale).
Exclusion criteria
Exclusion criteria: 1. Subjects who have undergone hair growth treatment within 6 months before screening into the study. 2. Subjects having any active scalp disease which may interfere in the study â?? dermatologistâ??s judgement. 3. Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study. 4. Subjects who have history of alcoholism, smoking, crash dieting and/ or psychiatric disorder including trichotillomania. 5. Subjects who have had hair transplant, who have taken pharmaceutical product which cause hirsutism (ex. phenytoin) and finasteride for androgenic alopecia, under medical treatment for hair problems. 6. A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products. 7. Subjects on oral medications, undergoing any chemical hair salon treatment-straightening / perming / colour which will compromise the study. 8. Subjects who are pregnant or lactating or nursing as established with medical history 9. Menopausal female subjects as determined by medical history. 10. Subjects with chronic illness which may influence the cutaneous state. 11. Subjects taking food or vitamin supplements that may comprise the study 12. A known history or present condition of allergic response to any pharmaceutical product/Ayurvedic/nutraceutical product 13. Subjects participating in other similar cosmetic or therapeutic trial within last three months. 14. Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Significant improvement in hair growth rate 2. Significant improvement in hair density 3. Significant improvement in hair strength 4. Significant reduction in hair fall with or without bulb 5. Improvement in new hair growth 6. Significant improvement in hair thinning 7. Significant improvement in hair qualityTimepoint: Day1, Day 3, Day 32, Day 62 and Day 92 | — |
Secondary
| Measure | Time frame |
|---|---|
| The product safety profile by dermatologistTimepoint: Day1, Day 3, Day 32, Day 62 and Day 92 | — |
Countries
India
Contacts
Public ContactSudhanthiran S
MS Clinical Research Pvt Ltd
Outcome results
None listed